Pancreatic Cancer Research

ResearcherWiener KrankenanstaltenverbundNo recent work listed

Christian Dittrich

Matched on ORCID iD 0000-0002-8153-6928; OpenAlex author ID A5009729018.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Co-author DOI 10.1200/jco.22.01134↗
  2. Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial. First author DOI 10.1007/s10637-018-0639-0↗
  3. Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic model. Co-author DOI 10.1007/s00280-018-3545-4↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Azra Sahmanovic Hrgovcic · 2 shared papers, 2018–2019
  2. Philipp Buchner · 2 shared papers, 2018–2019
  3. Andrea Grüber · 1 shared paper, 2018

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.